Bio Essence Corporation BIOE
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 416.59% | 586.28% | 485.68% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 416.59% | 586.28% | 485.68% | -- | -- |
| Cost of Revenue | 373.30% | 497.88% | 338.82% | -- | -- |
| Gross Profit | 438.03% | 626.63% | 557.95% | -- | -- |
| SG&A Expenses | -26.16% | -45.85% | -21.88% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.46% | 22.83% | 27.35% | -- | -- |
| Operating Income | 637.36% | 357.69% | 295.95% | -- | -- |
| Income Before Tax | 212.07% | 179.99% | 157.32% | -- | -- |
| Income Tax Expenses | 2,425.00% | 1,225.00% | 0.00% | -- | -- |
| Earnings from Continuing Operations | 210.53% | 179.30% | 157.24% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 210.53% | 179.30% | 168.47% | -- | -- |
| EBIT | 637.36% | 357.69% | 295.95% | -- | -- |
| EBITDA | 674.41% | 358.05% | 296.44% | -- | -- |
| EPS Basic | 204.16% | 177.42% | 168.41% | -- | -- |
| Normalized Basic EPS | 205.31% | 177.86% | 157.20% | -- | -- |
| EPS Diluted | 204.16% | 177.42% | 168.41% | -- | -- |
| Normalized Diluted EPS | 205.31% | 177.86% | 157.20% | -- | -- |
| Average Basic Shares Outstanding | 11.09% | 4.57% | 0.00% | -- | -- |
| Average Diluted Shares Outstanding | 11.09% | 4.57% | 0.00% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |